DCA Update
About two months ago I blogged several articles on a potential cancer cure called DCA. To date there has still been no start of an FDA-approved clinical trial so it looks like the conspiracy theorists were right – DCA is a common chemical that has no profit potential for big pharma so even though it shrunk several different types of human tumors in immuno-compromised rats 75% in 3 weeks with no adverse side effects, and even though it’s been used for decades in humans in treating chronic lactic acidosis so its safety was already well characterized in humans, no one will put up the hundreds of millions of dollars to test its efficacy as a chemotherapeutic for cancer. Well, after Read More ›